Granisol (granisetron HCl oral solution, from Hawthorn) is now available for the prevention of nausea and vomiting associated with cancer therapy.
Granisol, a selective 5-HT3 receptor antagonist, is the generic equivalent of Roche’s Kytril oral solution.